Barner on KSR Obviousness Case

Foley & Lardner LLP partner Lawrence Kraus is quoted in the Healthcare Risk Management article, "Loper Bright Starting to Affect False Claims Cases."

Foley & Lardner LLP partner David Rosen described the legal battle between compounding pharmacies and the U.S. Food and Drug Administration over GLP-1 drugs in the BioSpace article, "Legal Challenge Over Lilly’s GLP-1 Shortages Highlights FDA’s Post-Chevron Vulnerability."

Employee assistance programs have become an extremely common benefit offered by U.S. employers.